Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-21

FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)

View source ↗

Summary

The FDA approved a supplemental application for KALYDECO (ivacaftor) filed by Vertex Pharmaceuticals Incorporated. The action authorizes changes to the drug's l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kalydeco (ivacaftor)

Snippet

SUPPL AP for KALYDECO (IVACAFTOR)